Implications for clinical staging of metastatic cutaneous squamous carcinoma of the head and neck based on a multicenter study of treatment outcomes-Reference-Cited by-同舟云学术

Implications for clinical staging of metastatic cutaneous squamous carcinoma of the head and neck based on a multicenter study of treatment outcomes

Published:2006 Issue:5 Volume:106 Page:1078-1083
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Andruchow Jennifer L.,Veness Michael J.,Morgan Gary J.,Gao Kan,Clifford Anthony,Shannon Kerwin F.,Poulsen Michael,Kenny Lizbeth,Palme Carsten E.,Gullane Patrick,Morris Christopher,Mendenhall William M.,Patel Kepal N.,Shah Jatin P.,O'Brien Christopher J.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference11 articles.

1. SQUAMOUS CELL CARCINOMA OF THE SKIN OF THE TRUNK AND LIMBS: THE INCIDENCE OF METASTASES AND THEIR OUTCOME

2. Parotid and neck metastases from cutaneous squamous cell carcinoma of the head and neck

3. Carcinoma of the skin metastatic to the parotid area lymph nodes

4. Cutaneous head and neck squamous cell carcinoma metastatic to cervical lymph nodes (nonparotid): A better outcome with surgery and adjuvant radiotherapy

5. Incidence of cervical node involvement in metastatic cutaneous malignancy involving the parotid gland

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Results of surgical treatment of lymph node metastases in patients with cutaneous squamous cell carcinoma of the head and neck;Acta Otorrinolaringologica (English Edition);2024-05

2. Resultados del tratamiento quirúrgico de las metástasis ganglionares en pacientes con carcinomas escamosos cutáneos de cabeza y cuello;Acta Otorrinolaringológica Española;2023-11

3. Aggressive Cutaneous Squamous Cell Carcinoma of the Head and Neck: A Review;Current Oncology;2023-07-11

4. Evolution of Head and Neck Cutaneous Squamous Cell Carcinoma Nodal Staging—An Australian Perspective;Cancers;2022-10-18

5. American Head and Neck Society position statement on the use of PD ‐1 inhibitors for treatment of advanced cutaneous squamous cell carcinoma;Head & Neck;2022-09-30